ETRACS 2x Leveraged US Growth Factor TR ETN
IWFL
1 hedge funds and large institutions have $295K invested in ETRACS 2x Leveraged US Growth Factor TR ETN in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
24% more capital invested
Capital invested by funds: $239K → $295K (+$56.5K)
0% more funds holding
Funds holding: 1 → 1 (0)
0% more ownership
Funds ownership: 1.15% → 1.15% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
+$89 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
IMC Chicago
Chicago,
Illinois
| $295K | +$89 | +4 | +0% |
|
IWFL Hedge Fund Activity: Q2 2023 in Review
1 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) for Q2 2023, worth a combined $295K — up 24% from $239K a quarter earlier.
Fund positioning in IWFL was balanced in Q2 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was IMC Chicago, adding an estimated $89.
- 1 institutional investor held ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $295K of ETRACS 2x Leveraged US Growth Factor TR ETN stock for Q2 2023, up 24% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged US Growth Factor TR ETN positions in Q2 2023 and 0 closed out.
- The largest ETRACS 2x Leveraged US Growth Factor TR ETN buyer in Q2 2023 was IMC Chicago, an estimated $89 added.
Based on aggregated 13F filings for Q2 2023.